ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Atazanavir Sulfate; Cobicistat Tablet shortage

To Be Discontinued  1 presentations · 1 manufacturers · first FDA posting 2025-11-03 · last update 2025-11-03

Manufacturers: Bristol Myers Squibb Co.

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11)Bristol Myers Squibb Co.To Be Discontinued
 —The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026.Posted 11/03/2025
Updated 11/03/2025
Discontinued 11/03/2025

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)